Member of Lyonbiopole
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics.
BIOCORP is now a Novo Nordisk company.
Strategic application domain: Medical Technologies
Application market: Metabolic Disorders - Endocrinology
Type of activity: E-Health, Medical device
Technologies: Drug delivery device & Technologies
Created on jan. 1st, 2004 - 100 employees
Address
PT Lavaur La Béchade 63500 ISSOIRE
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.